José Valentín
García Gutiérrez
Profesor/a Asociado/a en CC. de la Salud
Princess Margaret Cancer Centre
Toronto, CanadáPublikationen in Zusammenarbeit mit Forschern von Princess Margaret Cancer Centre (5)
2023
2022
-
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial
Leukemia, Vol. 36, Núm. 7, pp. 1825-1833
-
CML-395 Efficacy and Safety Results From ASCEMBL, a Phase III Study of Asciminib vs. Bosutinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) After ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): Week 96 Update
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S295-S296
-
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an option
Blood Reviews, Vol. 56
2021
-
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs
Blood, Vol. 138, Núm. 21, pp. 2031-2041